Concept Life Sciences partners with Alderley Analytical ensuring bioanalytical and DMPK study services

In a bid to offer qualitative bioanalytical and DMPK study services, Concept Life Sciences and Alderly Analytical venture into partnership agreement enumerating having access to Alderley’s remarkable finesse in bioanalysis thereby benefiting from Concept’s grave knowledge of synthetic, organic and medicinal chemistry, biology, toxicology, and analytical services paving way for development services for quantification of new molecules in a biological matrix utilizing advanced instrumentation.

Michael Fort, Executive Chairman, Concept Life Sciences, commented: “The team at Alderley Analytical has built an impressive reputation for delivery of the highest quality GLP/GCP bioanalytical services. Combining this offering with our Group’s expertise, including the recent additions of translational biology and large molecule research, brings benefits to the widest group of life sciences clients.”